Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.052 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.024 | 0.7 |